AAAAAA
Results:
1-22
|
Results: 22
Authors:
COLLER JK
SOMOGYI AA
BOCHNER F
Citation: Jk. Coller et al., FLUNITRAZEPAM OXIDATIVE-METABOLISM IN HUMAN LIVER-MICROSOMES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 423-423
Authors:
VANAGS DM
LLOYD JV
RODGERS SE
BOCHNER F
Citation: Dm. Vanags et al., ADP, ADRENALINE AND SEROTONIN STIMULATE INOSITOL 1,4,5-TRISPHOSPHATE PRODUCTION IN HUMAN PLATELETS, European journal of pharmacology, 358(1), 1998, pp. 93-100
Authors:
COLLER JK
SOMOGYI AA
BOCHNER F
Citation: Jk. Coller et al., ASSOCIATION BETWEEN CYP2C19 GENOTYPE AND PROGUANIL OXIDATIVE POLYMORPHISM, British journal of clinical pharmacology, 43(6), 1997, pp. 659-660
Authors:
WHITE JM
BOCHNER F
IRVINE RJ
Citation: Jm. White et al., THE AGONY OF ECSTASY, Medical journal of Australia, 166(3), 1997, pp. 117-118
Authors:
BOCHNER F
BURGESS NG
MARTIN ED
Citation: F. Bochner et al., APPROACHES TO RATIONING DRUGS IN HOSPITALS - AN AUSTRALIAN PERSPECTIVE, PharmacoEconomics, 10(5), 1996, pp. 467-474
Authors:
SOMOGYI AA
REINHARD HA
BOCHNER F
Citation: Aa. Somogyi et al., PHARMACOKINETIC EVALUATION OF PROGUANIL - A PROBE PHENOTYPING DRUG FOR THE MEPHENYTOIN HYDROXYLASE POLYMORPHISM, British journal of clinical pharmacology, 41(3), 1996, pp. 175-179
Authors:
SOMOGYI AA
REINHARD HA
BOCHNER F
Citation: Aa. Somogyi et al., EFFECTS OF OMEPRAZOLE AND CIMETIDINE ON THE URINARY METABOLIC RATIO OF PROGUANIL IN HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 50(5), 1996, pp. 417-419
Authors:
CAPON DA
BOCHNER F
KERRY N
MIKUS G
DANZ C
SOMOGYI AA
Citation: Da. Capon et al., THE INFLUENCE OF CYP2D6 POLYMORPHISM AND QUINIDINE ON THE DISPOSITIONAND ANTITUSSIVE EFFECT OF DEXTROMETHORPHAN IN HUMANS, Clinical pharmacology and therapeutics, 60(3), 1996, pp. 295-307
Authors:
SOMOGYI AA
BOCHNER F
HETZEL D
WILLIAMS DB
Citation: Aa. Somogyi et al., EVALUATION OF THE INTESTINAL-ABSORPTION OF ERYTHROMYCIN IN MAN - ABSOLUTE BIOAVAILABILITY AND COMPARISON WITH ENTERIC-COATED ERYTHROMYCIN, Pharmaceutical research, 12(1), 1995, pp. 149-154
Authors:
BOCHNER F
LLOYD JV
Citation: F. Bochner et Jv. Lloyd, ASPIRIN FOR MYOCARDIAL-INFARCTION - CLINICAL PHARMACOKINETIC CONSIDERATIONS, Clinical pharmacokinetics, 28(6), 1995, pp. 433-438
Authors:
HEBBARD GS
SUN WM
BOCHNER F
HOROWITZ M
Citation: Gs. Hebbard et al., PHARMACOKINETIC CONSIDERATIONS IN GASTROINTESTINAL MOTOR DISORDERS, Clinical pharmacokinetics, 28(1), 1995, pp. 41-66
Authors:
BOCHNER F
MARTIN ED
BURGESS NG
SOMOGYI AA
MISAN GMH
ANTIC R
BARKER C
COBAIN W
DEVITT P
ERDT F
HORVATH N
LEE TI
LELEU L
MAGUIRE L
WILLIAMS JAR
YEOH E
Citation: F. Bochner et al., DRUG RATIONING IN A TEACHING HOSPITAL - A METHOD TO ASSIGN PRIORITIES, BMJ. British medical journal, 308(6933), 1994, pp. 901-905
Authors:
BOCHNER F
MARTIN ED
BURGESS NG
SOMOGYI AA
MISAN GMH
ANTIC R
BARKER C
COBAIN W
DEVITT P
ERDT F
HORVATH N
LEE TI
LELEU L
MAGUIRE L
WILLIAMS JAR
YEOH E
Citation: F. Bochner et al., CONTROVERSIES IN TREATMENT - HOW CAN HOSPITALS RATION DRUGS - RESPONSE, BMJ. British medical journal, 308(6933), 1994, pp. 907-908
Authors:
TONKIN AL
BOCHNER F
Citation: Al. Tonkin et F. Bochner, THERAPEUTIC DRUG-MONITORING AND PATIENT OUTCOME - A REVIEW OF THE ISSUES, Clinical pharmacokinetics, 27(3), 1994, pp. 169-174
Authors:
KERRY NL
SOMOGYI AA
BOCHNER F
MIKUS G
Citation: Nl. Kerry et al., THE ROLE OF CYP2D6 IN PRIMARY AND SECONDARY OXIDATIVE-METABOLISM OF DEXTROMETHORPHAN - IN-VITRO STUDIES USING HUMAN LIVER-MICROSOMES, British journal of clinical pharmacology, 38(3), 1994, pp. 243-248
Authors:
ZHANG CL
WILSON KM
STAFFORD I
BOCHNER F
HOROWITZ JD
Citation: Cl. Zhang et al., ABSORPTION KINETICS OF LOW-DOSE ASPIRIN IN PATIENTS WITH EVOLVING ACUTE MYOCARDIAL-INFARCTION, Drug investigation, 7(4), 1994, pp. 169-174
Authors:
BOCHNER F
SOMOGYI AA
CHEN ZR
Citation: F. Bochner et al., DEXTROMETHORPHAN METABOLISM IN RAT - INTERSTRAIN DIFFERENCES AND THE FATE OF INDIVIDUALLY ADMINISTERED OXIDATIVE METABOLITES, Xenobiotica, 24(6), 1994, pp. 543-552
Authors:
CLEARY J
MIKUS G
SOMOGYI A
BOCHNER F
Citation: J. Cleary et al., THE INFLUENCE OF PHARMACOGENETICS ON OPIOID ANALGESIA - STUDIES WITH CODEINE AND OXYCODONE IN THE SPRAGUE-DAWLEY DARK AGOUTI RAT MODEL-2, The Journal of pharmacology and experimental therapeutics, 271(3), 1994, pp. 1528-1534
Authors:
MIKUS G
BOCHNER F
EICHELBAUM M
HORAK P
SOMOGYI AA
SPECTOR S
Citation: G. Mikus et al., ENDOGENOUS CODEINE AND MORPHINE IN POOR AND EXTENSIVE METABOLIZERS OFTHE CYP2D6 (DEBRISOQUINE SPARTEINE) POLYMORPHISM/, The Journal of pharmacology and experimental therapeutics, 268(2), 1994, pp. 546-551
Authors:
SOMOGYI AA
NATION RL
OLWENY C
TSIRGIOTIS P
VANCRUGTEN J
MILNE RW
CLEARY JF
DANZ C
BOCHNER F
Citation: Aa. Somogyi et al., PLASMA-CONCENTRATIONS AND RENAL CLEARANCE OF MORPHINE, MORPHINE-3-GLUCURONIDE AND MORPHINE-6-GLUCURONIDE IN CANCER-PATIENTS RECEIVING MORPHINE, Clinical pharmacokinetics, 24(5), 1993, pp. 413-420
Authors:
HAYBALL PJ
NATION RL
BOCHNER F
SANSOM LN
AHERN MJ
SMITH MD
Citation: Pj. Hayball et al., THE INFLUENCE OF RENAL-FUNCTION ON THE ENANTIOSELECTIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF KETOPROFEN IN PATIENTS WITH RHEUMATOID-ARTHRITIS, British journal of clinical pharmacology, 36(3), 1993, pp. 185-193
Authors:
BOCHNER F
TONKIN A
Citation: F. Bochner et A. Tonkin, THE CLINICIAN AND THERAPEUTIC DRUG-MONITORING IN THE 1990S, Medical journal of Australia, 158(6), 1993, pp. 422-426
Risultati:
1-22
|